Published in Br J Cancer on November 02, 2001
Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev (2010) 3.95
MC1R variants increase risk of melanomas harboring BRAF mutations. J Invest Dermatol (2008) 1.72
Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis. Ann Epidemiol (2008) 1.22
PGC-1 coactivators regulate MITF and the tanning response. Mol Cell (2012) 1.07
Cutaneous melanoma and obesity in the Agricultural Health Study. Ann Epidemiol (2008) 1.06
On the interplay of telomeres, nevi and the risk of melanoma. PLoS One (2012) 0.87
Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk Factors. J Clin Exp Dermatol Res (2011) 0.85
Cigarette smoking and malignant melanoma: a case-control study. J Am Acad Dermatol (2010) 0.82
XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. Br J Cancer (2004) 0.82
Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families. J Invest Dermatol (2013) 0.78
Current Data on Risk Factor Estimates Does Not Explain the Difference in Rates of Melanoma between Hispanics and Non-Hispanic Whites. J Skin Cancer (2016) 0.78
Independent validation of six melanoma risk prediction models. J Invest Dermatol (2014) 0.75
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA (1997) 2.65
Personal risk-factor chart for cutaneous melanoma. Lancet (1989) 2.65
Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer (1995) 1.68
Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol (1994) 1.31
Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. J Natl Cancer Inst (2000) 1.29
Parallel risk assessment of melanoma and basal cell carcinoma: skin characteristics and sun exposure. Melanoma Res (1998) 1.05
Sunscreens and the risk of cutaneous malignant melanoma. Eur J Cancer Prev (1999) 0.98
Sunlamps and sunbeds and the risk of cutaneous melanoma. Italian Group for Epidemiological Research in Dermatology. Eur J Cancer Prev (2000) 0.96
Cutaneous malignant melanoma and sun exposure in Spain. Melanoma Res (1999) 0.95
Malignant melanoma in Italy: risks associated with common and clinically atypical melanocytic nevi. J Am Acad Dermatol (1995) 0.92
Risk factors for cutaneous malignant melanoma in a northern Italian population. Int J Cancer (1987) 0.87
Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation. Cancer Epidemiol Biomarkers Prev (1995) 0.83
Sunscreens and cutaneous malignant melanoma: an Italian case-control study. Int J Cancer (2000) 0.82
Rising melanoma incidence in an Italian community from 1986 to 1997. Melanoma Res (1999) 0.82
Genetic epidemiology of familial melanoma. Dermatol Clin (1995) 0.82
[Case-control study on malignant skin melanoma in the Turin province]. G Ital Dermatol Venereol (1988) 0.80
More about: sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. J Natl Cancer Inst (1999) 0.80
[Estimate of the proportion of skin tumors attributable to sun exposure in 3 Italian populations]. Epidemiol Prev (2000) 0.79
Clinical characteristics of 20 Italian melanoma-prone families. Arch Dermatol (1999) 0.79
Familial melanoma aggregation in north-eastern Italy. J Invest Dermatol (2000) 0.78
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997) 13.96
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res (1995) 5.72
Germline p16 mutations in familial melanoma. Nat Genet (1994) 5.59
Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med (1987) 4.12
Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet (1996) 3.53
CDKN2A mutations in multiple primary melanomas. N Engl J Med (1998) 3.52
Graphical presentation of trends in rates. Am J Epidemiol (1995) 3.09
Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03
Health effects of dioxin exposure: a 20-year mortality study. Am J Epidemiol (2001) 3.02
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet (1996) 2.96
Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr (1998) 2.82
Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst (2001) 2.73
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med (1985) 2.54
Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst (1993) 2.44
Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet (1995) 2.42
The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet (1998) 2.32
High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med (1998) 2.30
The Danish case-control study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int J Cancer (1988) 2.26
Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA (1993) 2.17
Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst (1987) 2.12
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med (2001) 2.11
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet (1999) 2.03
Environmental epigenetics. Heredity (Edinb) (2010) 1.99
Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst (1990) 1.86
Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost (1996) 1.83
Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res (1992) 1.78
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci U S A (1983) 1.72
Mutations associated with familial melanoma impair p16INK4 function. Nat Genet (1995) 1.69
Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med (1993) 1.66
Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med (1985) 1.64
Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (1999) 1.61
Biologically effective ultraviolet radiation: surface measurements in the United States, 1974 to 1985. Science (1988) 1.59
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2001) 1.51
High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med (1985) 1.51
Hereditary retinoblastoma and risk of lung cancer. J Natl Cancer Inst (2000) 1.51
Problems ascertaining friend controls in a case-control study of lung cancer. Am J Epidemiol (1991) 1.48
Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium. J Clin Oncol (1999) 1.47
Collection of buccal cell DNA using treated cards. Cancer Epidemiol Biomarkers Prev (2000) 1.46
Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. J Natl Cancer Inst (2000) 1.45
Arg506Gln factor V mutation and cerebral ischemia in the young. Stroke (1996) 1.42
Focal cerebral ischemia in young adults: a collaborative case-control study. The National Research Council Study Group. Neuroepidemiology (1993) 1.40
Mutation rate estimate in hereditary cutaneous malignant melanoma/dysplastic nevi. Am J Med Genet (1990) 1.40
Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev (1995) 1.39
Increased risk of neuroectodermal tumors and stomach cancer in relatives of patients with Ewing's sarcoma family of tumors. J Natl Cancer Inst (1994) 1.39
Publication bias via suppressed criticism. Lancet (1993) 1.39
Day hospital rehabilitation--effectiveness and cost in the elderly: a randomised controlled trial. Br Med J (Clin Res Ed) (1984) 1.38
Effects of inhalable particulate matter on blood coagulation. J Thromb Haemost (2009) 1.34
Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am J Hum Genet (1998) 1.33
A second maternally expressed Drosophila gene encodes a putative RNA helicase of the "DEAD box" family. Proc Natl Acad Sci U S A (1991) 1.32
Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet (1982) 1.31
The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors. Int J Cancer (1988) 1.25
Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci U S A (1989) 1.21
Recurrent ischemic attacks in two young adults with lupus anticoagulant. Stroke (1984) 1.20
Intestinal side-effects of docetaxel/vinorelbine combination. Lancet (2000) 1.19
Adverse effects of trichothiodystrophy DNA repair and transcription gene disorder on human fetal development. Clin Genet (2009) 1.18
Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis (2006) 1.17
Genetic epidemiology of cutaneous melanoma: a global perspective. Arch Dermatol (2001) 1.15
DNA methylation in repetitive elements and Alzheimer disease. Brain Behav Immun (2011) 1.15
Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet (1980) 1.12
Prospective risk of cancer in CDKN2A germline mutation carriers. J Med Genet (2004) 1.10
Prognostic significance of hyperglycemia in acute stroke. Arch Neurol (1985) 1.10
Blood leukocyte Alu and LINE-1 methylation and gastric cancer risk in the Shanghai Women's Health Study. Br J Cancer (2011) 1.08
Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. Am J Hum Genet (1993) 1.08
Digital subtraction angiography in patients with cerebral ischaemic attacks and normal continuous wave Doppler studies. J Neurol Neurosurg Psychiatry (1985) 1.07
Cancer mortality of capacitor manufacturing workers. Am J Ind Med (1987) 1.07
Late effects of therapy in survivors of Ewing's sarcoma family tumors. J Pediatr Hematol Oncol (1997) 1.06
Childhood cancer in sibs. J Pediatr (1976) 1.05
Prophylactic oophorectomy in inherited breast/ovarian cancer families. J Natl Cancer Inst Monogr (1995) 1.04
A genome screen of families at high risk for Hodgkin lymphoma: evidence for a susceptibility gene on chromosome 4. J Med Genet (2005) 1.04
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J Natl Cancer Inst (2010) 1.04
Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control study. Br J Cancer (2011) 1.02
Mutation testing in melanoma families: INK4A, CDK4 and INK4D. Br J Cancer (1999) 1.01
Mutation screening of the CDKN2A promoter in melanoma families. Genes Chromosomes Cancer (2000) 1.01
Second cancers after medulloblastoma: population-based results from the United States and Sweden. Cancer Causes Control (1997) 1.00
Survival patterns for malignant mesothelioma: the SEER experience. Int J Cancer (1988) 1.00
Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82. Natl Cancer Inst Monogr (1985) 0.99
Validation of family history of cancer in deceased family members. J Natl Cancer Inst (1996) 0.99
Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families. J Pediatr (1983) 0.98
Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations. Int J Cancer (1997) 0.98
Non ischaemic causes of lacunar syndromes: prevalence and clinical findings. J Neurol Neurosurg Psychiatry (1989) 0.98
Genetic susceptibility in familial melanoma from northeastern Italy. J Med Genet (2004) 0.98
Case-control study of female hormones and eye melanoma. Cancer Res (1989) 0.97
The Danish case-control study of cutaneous malignant melanoma. IV. No association with nutritional factors, alcohol, smoking or hair dyes. Int J Cancer (1988) 0.96
The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Int J Cancer (1988) 0.96
Daytime napping: Effects on human direct associative and relational memory. Neurobiol Learn Mem (2010) 0.96
Validation of a brief screening test for depression in the elderly. Age Ageing (1987) 0.95
Lipid and endothelium-related genes, ambient particulate matter, and heart rate variability--the VA Normative Aging Study. J Epidemiol Community Health (2010) 0.94
The Italian version of the Mouth Handicap in Systemic Sclerosis scale (MHISS) is valid, reliable and useful in assessing oral health-related quality of life (OHRQoL) in systemic sclerosis (SSc) patients. Rheumatol Int (2011) 0.94
A randomized trial of aspirin and sulfinpyrazone in patients with TIA. Stroke (1982) 0.94
Familial eosinophilia: clinical and laboratory results on a U.S. kindred. Am J Med Genet (1998) 0.93
Efficacy of a tailored rehabilitation program for systemic sclerosis. Clin Exp Rheumatol (2009) 0.93
Effect of heavy medical expenditures on low income families. Public Health Rep (1970) 0.92
Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma. J Med Genet (2005) 0.92
Common genetic variants in the 9p21 region and their associations with multiple tumours. Br J Cancer (2013) 0.92
A study of gender-based cytochrome P4501A2 variability: a possible mechanism for the male excess of bladder cancer. Cancer Epidemiol Biomarkers Prev (1995) 0.92
Ozone exposure, antioxidant genes, and lung function in an elderly cohort: VA normative aging study. Occup Environ Med (2008) 0.91
Hereditary melanoma and the dysplastic nevus syndrome: the risk of cancers other than melanoma. J Am Acad Dermatol (1987) 0.91
Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution. Eur J Cancer (2001) 0.91